Life Sciences

Welcome to the 'Life Sciences' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Life Sciences'.

Latest blogosphere posts tagged “Life Sciences”

• Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M

  
  Xconomy — Authority: 712
  Biotech , deals , startups Luke Timmerman wrote: Ironwood Pharmaceuticals is gearing up for the possibility of an IPO. The Cambridge, MA-based developer of a new treatment for bowel disorders like for irritable bowel syndrome and chronic constipation said it may raise as much as $172.5 million from ...
  1 day ago

• Blue Marble Snags $2M State Grant

  
  Xconomy — Authority: 712
  cleantech , Biofuels , startups Luke Timmerman wrote: Seattle-based Blue Marble Energy , the developer of renewable energy and specialty chemicals from biomass, said it has received a $2 million state grant through a partnership with the Odessa Public Development Authority. The company plans to use the ...
  2 days ago

• Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder

  
  Xconomy — Authority: 712
  Biotech , Drugs , Multiple Sclerosis Luke Timmerman wrote: After a bitter standoff earlier this year with billionaire investor Carl Icahn over alleged mismanagement , Cambridge, MA-based Biogen Idec now faces another sharp attack from a major shareholder. New York-based HealthCor Management, a hedge ...
  2 days ago

• $31.3M for Cambridgesoft

  
  Xconomy — Authority: 712
  IT , Life Sciences , deals Wade Roush wrote: Cambridge, MA-based Cambridgesoft , which makes software for life sciences companies, disclosed in regulatory documents filed November 17 that it has raised $31.3 million in new equity-based financing. Cambridgesoft first announced the funding round (though ...
  2 days ago

• Dendreon FDA Deadline Set For May 1

  
  Xconomy — Authority: 712
  Biotech , cancer , Drugs Luke Timmerman wrote: Seattle-based Dendreon (NASDAQ: DNDN ), the developer of what it hopes will be the first FDA-approved treatment to actively stimulate the immune system against cancer, said today the U.S. regulatory agency has received its amended application and set a ...
  2 days ago

• Paleontologists Find Extinction Rates Higher in Open-Ocean Settings During Mass Extinctions

  
  OK4me2 — Authority: 153
  Ocean-facing coastline. There is a major dichotomy observed among marine sedimentary rocks and fossils: the distinction between epicontinental seas, which were broad shallow seas (typically less than 100 meters in depth) that once covered large regions of present-day continents, and open-ocean-facing coastlines, such ...
  2 days ago

• Metcalfe Reflects on $2.7B 3Com Buyout, $30M More for Fate Therapeutics, & More Boston Deals News

  
  Xconomy — Authority: 712
  deals , VC , mergers and acquisitions Ryan McBride wrote: Dealmakers appear to be getting their business done before the week of Thanksgiving—because we’ve seen a decent stream of deal closings involving Boston-area life sciences and tech companies over the past week or so. —Framingham, MA-based ...
  2 days ago

• Under the Radar Deals: 12 Northwest Financings You Haven’t Heard About

  
  Xconomy — Authority: 712
  deals , startups , Investments Gregory T. Huang wrote: We hope to make this a regular feature in our Xconomy cities. It’s a look at small financings of private companies in tech, life sciences, and cleantech. These are deals in the roughly $100,000 to $1 million range, and they’re increasingly where ...
  2 days ago

• Omeros Banks on First FDA Filing Next Year, Plans to “Unlock” Inaccessible Drug Targets

  
  Xconomy — Authority: 712
  Biotech , Knee Surgery , Drugs Luke Timmerman wrote: Seattle-based Omeros expects to apply for FDA clearance to start selling its first product by the second half of next year, and it also hoping to strike at least one partnership over the next couple of years with a bigger drugmaker, CEO Greg Demopulos ...
  3 days ago

• ImmunoGen Nabs $1M From Amgen

  
  Xconomy — Authority: 712
  Biotech , deals , cancer Luke Timmerman wrote: Waltham, MA-based ImmunoGen (NASDAQ: IMGN ) said today that Amgen has purchased a second license to develop a treatment that uses ImmunoGen’s technology for linking targeted antibodies to cell-killing agents that make them more potent. ImmunoGen will get ...
  3 days ago

• BIOTECH TRAINEE JOBS DELHI/NCR-ALLELE LIFE SCIENCES

  
  VFRESHERS — Authority: 159
  Biotech ( Trainee ) Job Positions India at Delhi/NCR – Allele Life SciencesJob Title : Biotech ( Trainee )Company Name : Allele Life Sciences (P) LtdAbout Company : Allele Life Sciences (P) Ltd is an ISO 9001:2000 certified company in Biotechnology Research , Testing Services , Sales and Marketing of Biotech ...
  3 days ago

• $5.3M for Corindus

  
  Xconomy — Authority: 712
  medical devices , Life Sciences , VC Ryan McBride wrote: Natick, MA-based Corindus has corralled $5.3 million of a proposed $10 million round of equity financing, according to an SEC filing . The firm is developing a robotic system that helps surgeons control the position of guidewires in veins in ...
  3 days ago

• United States Takes a Step Towards Isotope Independence

  
  Science Progress — Authority: 463
  Earlier this month, the House passed a bill that will protect as many as 50,000 nuclear medical procedures a day in the United States. That’s how many procedures rely on nuclear isotopes produced by foreign reactors. The United States has been at risk of experiencing a shortage of these isotopes since the Chalk ...
  3 days ago

• Ligon Discovery Seeded with $1M

  
  Xconomy — Authority: 712
  Life Sciences , startups , VC Ryan McBride wrote: Ligon Discovery reported today on its website that it has raised $1 milllion in seed financing from incTANK Ventures. The Cambridge, MA-based startup says it uses a small molecule microarray system developed at Harvard University to discover drugs, and ...
  3 days ago

• New Partner at Braemar Energy Ventures

  
  Xconomy — Authority: 712
  energy , VC , IT Ryan McBride wrote: Braemar Energy Ventures, a venture firm focused on investments in the cleantech sector, has named Jiong Ma a partner of the firm, according to a Mass High Tech report . She was previously a principal at the firm, which has offices in Boston and New York City, according ...
  3 days ago

• New on-Off ‘Switch’ Triggers and Reverses Paralysis in Animals With a Beam of Light

  
  Impact Lab — Authority: 522
  This tiny worm became temporarily paralyzed when scientists fed it a light-sensitive material, or “photoswitch,” and then exposed it to ultraviolet light.In an advance with overtones of Star Trek phasers and other sci-fi ray guns, scientists in Canada are reporting development of an internal on-off “switch” ...
  3 days ago

• Ligand Nabs $2M From Merck

  
  Xconomy — Authority: 712
  Biotech , deals , Life Sciences Luke Timmerman wrote: San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND ) said today it has received $2 million in milestone payments as part of research collaboration with Merck that is due to expire next month. The partnership started with Organon, which was later ...
  3 days ago

• Tysabri, the MS Drug Haunted by Deadly Side Effect, Doesn’t Look So Deadly Anymore

  
  Xconomy — Authority: 712
  Biotech , Multiple Sclerosis , Drugs Luke Timmerman wrote: Few doctors knew much about a rare brain infection called PML back in 2005, when two patients on a hot new multiple sclerosis drug from Biogen Idec and Elan died from the side effect. The infection, at the time, was generally considered a ...
  3 days ago

• Isis Extends Timeline on Cholesterol-Lowering Drug, FDA Delays Review of Cadence Pain Reliever, Fate Therapeutics Raises $30 Million, & More San Diego Life Sciences News

  
  Xconomy — Authority: 712
  Roundup , Life Sciences , funding Denise Gellene wrote: Drug development programs got extended at two San Diego life sciences companies, while others had some good news on the fund-raising front. We wrap it all up for you here. — Fate Therapeutics , a startup working to supply “industrialized” stem ...
  3 days ago

• The Icos Alumni Guide, Trubion CEO Resigns, OVP Leads $30M Fate Deal, & More Seattle-Area Life Sciences News

  
  Xconomy — Authority: 712
  Roundup , Biotech , people Luke Timmerman wrote: Three years have gone by since the region’s top biotech company was taken over by Eli Lilly, so it seemed like a good time to find out where all that talent migrated around the Northwest. — Icos was once the great hope for Seattle biotech, but now ...
  3 days ago

Comments about Life Sciences